Shenzhen - Delayed Quote CNY
Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ)
21.83
+0.62
+(2.92%)
At close: 3:04:19 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Zhi Hui Zhang | GM, MD & Director | -- | -- | 1971 |
| Mr. Dongqi Yuan | Deputy GM & CFO | -- | -- | 1977 |
| Mr. Fei Miao | Deputy GM & Secretary | -- | -- | 1976 |
| Mr. Haifeng Ying | Deputy General Manager | -- | -- | 1976 |
| Yanfei Shi | Accounting Supervisor | -- | -- | -- |
Jiangsu Apon Medical Technology Co., Ltd.
East side of Yongtong Avenue
Rudong Economic Development Zone
Nantong
China
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
- Full Time Employees:
- 608
Description
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. Its principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers in the field of nasal care. Jiangsu Apon Medical Technology Co., Ltd. was founded in 2001 and is headquartered in Nantong, China.
Corporate Governance
Jiangsu Apon Medical Technology Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 3, 2024 at 12:00 AM UTC
Ex-Dividend Date